Company intelligence / Profile preview

Cortexx Medical Intelligence

Paris, Île-de-France, Francelinkedin.com ↗

Ownership: Private
Employees: ~4
Development stage: Commercial

Overview

SuMO provides personalized analysis for patients undergoing back surgeries, identifying high-risk patients with over 80% accuracy. It recommends optimal timing for operations and projects up to 50% reduction in direct/indirect costs related to lumbar interventions in more than 25% of operated patients. The technology is being adapted to hip, digestive, and cardiac surgeries as well.

Therapeutic areas: OtherCardiovascularGastroenterology
Modalities: DeviceNon-pharmacological therapyDigital health platform
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Cortexx Medical Intelligence.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cortexx Medical Intelligence.

Explore the full profile